STSS Key Statistics, Chart & Performance
The current stock price of STSS is 2.24 USD. In the past month the price decreased by -24.07%. In the past year, price decreased by -99.66%.
STSS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.64 | 16.13B | ||
| SOLV | SOLVENTUM CORP | 13.3 | 13.71B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.14 | 11.20B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.24 | 5.13B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.29 | 4.46B | ||
| HAE | HAEMONETICS CORP/MASS | 16.66 | 3.74B | ||
| ICUI | ICU MEDICAL INC | 17.4 | 3.42B | ||
| XRAY | DENTSPLY SIRONA INC | 7.13 | 2.25B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.89 | 1.72B | ||
| NEOG | NEOGEN CORP | 23.33 | 1.52B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.17B | ||
| EMBC | EMBECTA CORP | 3.93 | 682.23M |
Related stock screener links
About STSS
Company Profile
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Company Info
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK US
Employees: 5
Phone: 15162464000
SHARPS TECHNOLOGY INC / STSS FAQ
What does STSS do?
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
What is the stock price of SHARPS TECHNOLOGY INC today?
The current stock price of STSS is 2.24 USD. The price increased by 10.34% in the last trading session.
Does STSS stock pay dividends?
STSS does not pay a dividend.
How is the ChartMill rating for SHARPS TECHNOLOGY INC?
STSS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in SHARPS TECHNOLOGY INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on STSS.
Can you provide the growth outlook for SHARPS TECHNOLOGY INC?
The Revenue of SHARPS TECHNOLOGY INC (STSS) is expected to decline by -95.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for SHARPS TECHNOLOGY INC?
SHARPS TECHNOLOGY INC (STSS) has a market capitalization of 63.24M USD. This makes STSS a Micro Cap stock.
STSS Technical Analysis
STSS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to STSS. The financial health of STSS is average, but there are quite some concerns on its profitability.
STSS Financial Highlights
Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of -689.83. The EPS increased by 72.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.51% | ||
| ROE | -24.09% | ||
| Debt/Equity | 0.02 |
STSS Forecast & Estimates
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 901.79% is expected in the next year compared to the current price of 2.24.
For the next year, analysts expect an EPS growth of -633.33% and a revenue growth -95.06% for STSS